As of April 28, 2026, Nuvectis Pharma's top three insider holders are Ron Bentsur (Chairman Ceo, 3.68Mn shares), Marlio Charles Mosseri (TenPercentOwner, 3.14Mn shares), Ron Bentsur (Chairman Ceo, 2.83Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Ron Bentsur | Chairman Ceo | 3,675,924 | 0 | 09 Jan, 2026 |
| Marlio Charles Mosseri | - | 0 | 3,136,576 | 29 Oct, 2025 |
| Ron Bentsur | Chairman Ceo | 2,825,459 | 0 | 29 Mar, 2022 |
| Marlio Charles Mosseri | - | 2,612,000 | 0 | 16 Dec, 2024 |
| Enrique Poradosu | Chief Science Business Off | 1,806,319 | 0 | 09 Jan, 2026 |
| Shay Shemesh | Chief Dev. Ops. Officer | 1,793,068 | 0 | 09 Jan, 2026 |
| Enrique Poradosu | Chief Science Business Off | 1,197,649 | 0 | 08 Feb, 2022 |
| Shay Shemesh | Chief Development Officer | 1,179,615 | 0 | 08 Feb, 2022 |
| Michael J. Carson | Vice President, Finance | 200,118 | 0 | 09 Jan, 2026 |
| Kenneth Hoberman | - | 133,140 | 0 | 12 Jun, 2025 |
| Matthew L. Kaplan | - | 124,760 | 0 | 06 Nov, 2025 |
| James F Iii Oliviero | - | 87,828 | 0 | 12 Jun, 2025 |
| Juan Sanchez | - | 78,150 | 0 | 06 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Jan, 2026 | Michael J. Carson | Common Stock | A | 61,200 | $0.00 | 200,118 | D | A |
| 06 Jan, 2026 | Ron Bentsur | Common Stock | A | 150,000 | $0.00 | 3,675,924 | D | A |
| 06 Jan, 2026 | Enrique Poradosu | Common Stock | A | 150,000 | $0.00 | 1,806,319 | D | A |
| 06 Jan, 2026 | Shay Shemesh | Common Stock | A | 150,000 | $0.00 | 1,793,068 | D | A |
| 05 Nov, 2025 | Matthew L. Kaplan | Common Stock | A | 11,000 | $5.84 | 124,760 | D | P |
| 05 Nov, 2025 | Ron Bentsur | Common Stock | A | 5,000 | $5.72 | 3,525,924 | D | P |
| 05 Nov, 2025 | Juan Sanchez | Common Stock | A | 13,000 | $5.79 | 78,150 | D | P |
| 22 Sep, 2025 | Juan Sanchez | Common Stock | A | 30,000 | $0.00 | 65,150 | D | A |
| 23 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 46,900 | $6.06 | 3,028,706 | I | P |
| 24 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 35,034 | $6.15 | 3,063,740 | I | P |
| 27 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 72,836 | $6.28 | 3,136,576 | I | P |
| 20 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 5,603 | $7.99 | 2,981,806 | I | P |
| 17 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 5,399 | $8.11 | 2,948,160 | I | P |
| 18 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 28,043 | $8.05 | 2,976,203 | I | P |
| 12 Jun, 2025 | James F Iii Oliviero | Common Stock | A | 30,000 | $0.00 | 87,828 | D | A |
| 12 Jun, 2025 | Kenneth Hoberman | Common Stock | A | 30,000 | $0.00 | 133,140 | D | A |
| 12 Jun, 2025 | Matthew L. Kaplan | Common Stock | A | 30,000 | $0.00 | 113,760 | D | A |
| 12 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 21,167 | $8.11 | 2,942,761 | I | P |
| 08 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 100 | $8.99 | 2,909,032 | I | P |
| 08 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 100 | $8.71 | 2,909,132 | I | P |